Differential effects of stimulatory factors on natural killer cell activities of young and aged mice

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 9, 2012, Pages 947-954

  Nogusa, Shoko ^a   Murasko, Donna M ^a   Gardner, Elizabeth M ^b  

^a DREXEL UNIVERSITY   (United States)

^b Michigan State University   (United States)

Author keywords

Aging; Cytokines; NK cells

Indexed keywords

MUS;

CYTOKINE; GAMMA INTERFERON; GRANZYME; GZMB PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; PERFORIN, MOUSE; PORE FORMING CYTOTOXIC PROTEIN;

AGING; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CYTOTOXICITY; DRUG EFFECT; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MOUSE; NATURAL KILLER CELL;

ADJUVANTS, IMMUNOLOGIC; AGING; ANIMALS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-18; INTERLEUKIN-2; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS;

EID: 84865802399     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls079     Document Type: Article

References (68)

1. Neff-LaFord HD, Vorderstrasse BA, Lawrence BP. Fewer CTL, not enhanced NK cells are sufficient for viral clearance from the lungs of immunocompromised mice. Cell Immunol. 2003; 226: 54-64.
2. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol. 2001; 13: 458-464.
3. Janeway CA, Travers P, Walport M, Shlomchik M. Immunobiology: The Immune System in Health and Disease. 5th ed. New York, NY: Garland Publishing; 2001.
4. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine. 2000; 18 (6): 1613-1620.
5. Albright JW, Bream JH, Bere EW, Young HA, Winkler-Pickett R, Ortaldo JR. Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2. Exp Gerontol. 2004; 39: 73-82.
6. Tarazona R, Casado JG, Delarosa O, et al. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naïve HIV-1-seropositive individuals. J Clin Immunol. 2002; 22 (3): 176-183.
7. Plett A, Murasko DM. Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta. Mech Ageing Dev. 2000; 112 (3): 197-215.
8. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol. 2000; 122: 197-215.
9. Sansoni P, Cossarizza A, Brianti V, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 1993; 82 (9): 2767-2773.
10. Fehniger TA, Cai SF, Cao X, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007; 26: 798-811.
11. Toomey JA, Gays F, Foster D, Brooks CG. Cytokine requirements for the growth and development of mouse NK cells in vitro. J Leukoc Biol. 2003; 74: 233-242.
12. Lauwerys BR, Renauld JC, Houssiau FA. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine. 1999; 11: 822-830.
13. Provinciali M, Muzzioli M, Fabris N. Timing of appearance and disappearance of IFN and IL-2 induced natural immunity during ontogenetic development and aging. Exp Gerontol. 1989; 24: 227-236.
14. Hefeneider SH, Conlon PJ, Henney CS, Gillis S. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol. 1983; 130 (1): 222-227.
15. Wright SC, Bona Vida B. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). J Immunol. 1983; 130 (6): 2961-2964.
16. Gallucci RM, Meadows GG. Ethanol consumption suppress the IL2-induced proliferation of NK cells. Toxicol Appl Pharmacol. 1996; 138: 90-97.
17. Lucini W, Boraschi D, Aleotti AA, Tagliabue A. Morphological characterization of a cell population responsible for natural killer activity. Immunology. 1981; 43: 663-668.
18. Wright SC, Bona Vida B. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). J Immunol. 1983; 160 (6): 2965-2968.
19. Haller O, Kiessling R, Orn A, Karre K, Nilsson K, Wigzell H. Natural cytotoxicity to human leukemia mediated by mouse non-T cells. Int J Cancer. 1977; 20: 93-103.
20. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol. 1977; 7: 655-663.
21. Kiessling R, Klein E, Pross H, Wigzell H. " Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Maloney leukemia cells. Characteristics of the killer cell. Eur J Immunol. 1975; 5: 117-121.
22. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975; 16: 216-229.
23. Murasko DM, Gardner EM. Immunology of aging. In: Hazzard WR, Blass JP, Halter JB, Ouslander JG, Tinetti ME, eds. Principles of Geriatric Medicine and Gerontology. 5th ed. New York, NY: McGraw-Hill; 2003: 35-52.
24. Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev. 2008; 129: 223-230.
25. Misawa E, Sakurai T, Yamada M, Hayasawa H, Motoyoshi K. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1+ cells in mice. Int J Immunopharmacol. 2000; 22: 967-977.
26. Speziali E, Aranha CHM, Teixeira-Carvalho A, et al. Aging downmodulates liver inflammatory immune responses to schistosome infection in mice. Scand J Immunol. 2010; 71: 240-248.
27. Nguyen KB, Salazar-Mather TP, Dalod MY, et al. Coordinated and distinct roles for IFN-α/β, IL-12, and IL-15 regulation of NK cell response to viral infection. J Immunol. 2002; 169 (8): 4279-4287.
28. Biron CA, Seb GC. Interferons and other cytokines. In: Knipe DM, Howley EM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE, eds. Fields Virology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001: 321-351.
29. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infected and virusinduced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001; 12: 171-180.
30. Pien GC, Satoskar AR, Takeda K, Akira S, Biron CA. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-γ responses during viral infection. J Immunol. 2000; 165: 4787-4791.
31. Cousens LP, Orange JS, Su HC, Biron CA. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA. 1997; 94: 634-639.
32. Godney EK, Gauntt CJ. Involvement of natural killer cells in coxsackie virus B3-induced murine myocarditis. J Immunol. 1986; 137: 1695-1702.
33. Chiax J, Tessmer MS, Hoebe K, et al. Cutting edge: priming of NK cells by IL-18. J Immunol. 2008; 181: 1627-1631.
34. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity. 2007; 26: 503-517.
35. Walker W, Aste-Amezaga M, Kastelein RA, Trinchieri G, Hunter CA. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-γ. J Immunol. 1999; 162: 5894-5901.
36. Prajeeth CK, Haeberlein S, Sebald H, Schleicher U, Bogdan C. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not NK cell cytotoxicity. Infect Immun. 2011; 79 (7): 2699-2708.
37. Wu CY, Wang X, Gadiana M, O'Shea JJ, Presky DH, Magram J. IL-12 receptor β 2 (IL-12R β 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J Immunol. 2000; 165: 6211-6228.
38. Hyodo Y, Matsui K, Hayashi N, et al. IL-18 up-regulate perforinmediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol. 1999; 162: 1662-1668.
39. Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 1998; 8: 383-390.
40. Wu CY, Ferrante J, Gately MK, Magram J. Characterization of IL-12 receptor β 1 chain (IL-12R β 1)-deficient mice-IL-12R β 1 is an essential component of the functional mouse IL-12 receptor. J Immunol. 1997; 159: 1658-1665.
41. Tomala J, Chmelova H, Strohalm J, et al. Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes synergizes with that of HPMA copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity. Int J Cancer. 2010; 129 (8): 2002-2012.
42. Fehniger TA, Shah MH, Turner MJ, et al. Differential cytokine and chemokine in combination with IL-12: implications for the innate immune response. J Immunol. 1999; 162: 4511-4520.
43. Weigent DA, Stanton GJ, Johnson HM. Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun. 1983; 41: 992-997.
44. Barton K, Muthusamy N, Fischer C, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998; 9: 555-563.
45. Plett PA, Gardner EM, Murasko DM. Age-related changes in interferon-α/β receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev. 2000; 118: 129-144.
46. Simon MM, Hausmann M, Tran T, et al. In vitro-and ex vivo-derived cytolytic leukocytes from granzyme A × B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med. 1997; 186 (10): 1781-1786.
47. Conn CA, McDlellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ. Cytokines and the acute phase response to influenza virus in mice. Am J Physiol. 1995; 268: 78-84.
48. Hennet T, Ziltener HJ, Frei K, Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol. 1992; 149 (3): 932-939.
49. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci USA. 2009; 106 (6): 1915-1919.
50. Haddad EA, Senger LK, Takei F. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells. J Immunol. 2009; 183: 3608-3615.
51. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol. 2006; 176: 1517-1524.
52. Gill N, Paltser G, Ashkar AA. Interleukin-15 expression affects homeostasis and function of B cells through NK cell-derived interferon-γ. Cell Immunol. 2009; 258: 59-64.
53. Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med. 2003; 197: 967-976.
54. Fehniger TA, Suzuki K, Ponnappan A, et al. Fetal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8 + T cells. J Exp Med. 2001; 193: 219-231.
55. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998; 9: 669-676.
56. French AR, Holroyd EB, Yang L, Kim S, Yokoyama WM. IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation . Cytokine. 2006; 35: 229-234.
57. Chakir H, Lemay AM, Webb JR. Cytokine expression by murine DX5 + cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18. Cell Immunol. 2001; 212: 71-81.
58. Zompi S, Hamerman JA, Ogasawara K, et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol. 2003; 4: 565-572.
59. Pande D, Rivera P, Marcenaro S, et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002; 62: 6178-6186.
60. Sivori S, Vitale M, Morelli L, et al. p46, a novel natural killer cellspecific surface molecule that mediates cell activation. J Exp Med. 1997; 186: 1129-1136.
61. Almeida-Oliveira A, Smith-Carvalho M, Porto LC, et al. Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol. 2011; 72 (4): 319-329.
62. Gayoso I, Sanchez-Correa B, Campos C, et al. Immunosenescence of human natural killer cells. J Innate Immun. 2011; 3 (4): 337-343.
63. Borrego F, Alonso MC, Galiani MD, et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol. 1999; 34 (2): 253-265.
64. Shresta S, MacIvor DM, Huesel JW, Russel JH, Ley TJ. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA. 1995; 92: 5679-5683.
65. Lowin B, Beermann F, Schmidt A, Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte-and natural killer cellmediated cytotoxicity. Proc Natl Acad Sci USA. 1994; 91: 11571-11575.
66. Chen H, Paul WE. Cultured NK1.1 + CD4 + T cells produce large amounts of IL-4 and IFN-γ upon activation by Anti-CD3 or CD1. J Immunol. 1997; 159: 2240-2249.
67. Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8 T cells secreting Th1 or Th2 cytokines. Immunity. 1995; 2 (3): 271-279.
68. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998; 8 (5): 591-599.